CA Stock MarketDetailed Quotes

ENBI Entheon Biomedical Corp

Watchlist
  • 0.090
  • 0.0000.00%
15min DelayMarket Closed Jul 31 14:51 ET
797.30KMarket Cap-1500P/E (TTM)

Entheon Biomedical Corp Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)May 31, 2024
(Q1)Feb 29, 2024
(FY)Nov 30, 2023
(Q4)Nov 30, 2023
(Q3)Aug 31, 2023
(Q2)May 31, 2023
(Q1)Feb 28, 2023
(FY)Nov 30, 2022
(Q4)Nov 30, 2022
(Q3)Aug 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments
-38.57%299.14K
-49.09%249.92K
-49.33%344.63K
-49.33%344.63K
53.72%381.81K
4.14%486.93K
-40.23%490.91K
-66.81%680.17K
-66.81%680.17K
-92.66%248.39K
-Cash and cash equivalents
-37.49%299.14K
-49.09%249.92K
-49.33%344.63K
-49.33%344.63K
53.72%381.81K
2.35%478.56K
-40.23%490.91K
-66.81%680.17K
-66.81%680.17K
-92.66%248.39K
Total current assets
-39.86%330.38K
-55.60%286.9K
-46.78%396.08K
-46.78%396.08K
-28.29%420.87K
-50.46%549.32K
-62.70%646.21K
-76.80%744.22K
-76.80%744.22K
-85.16%586.9K
Non current assets
-Accumulated depreciation
----
----
----
----
----
----
----
----
----
---81.26K
Investment properties
----
----
----
----
----
----
----
----
----
18.26%529.64K
-Including:Financial assets designated as fair value through profit or loss, Total
----
----
----
----
----
----
----
----
----
18.26%529.64K
-Goodwill
----
----
----
----
----
----
----
----
----
-7.39%5.42M
Regulatory assets
-43.12%4.03K
-92.23%6.45K
-85.23%6.23K
-85.23%6.23K
-75.69%10.87K
-76.30%7.08K
255.94%83K
49.10%42.19K
49.10%42.19K
5.86%44.72K
Liabilities
Current liabilities
-accounts payable
----
-66.16%51.01K
-44.83%85.33K
-44.83%85.33K
-33.77%41.57K
-89.38%89.04K
-84.44%150.73K
-83.33%154.65K
-83.33%154.65K
-84.06%62.76K
-Total tax payable
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
-Other payable
-80.00%5K
-80.00%5K
-80.00%5K
-80.00%5K
--10K
--25K
--25K
--25K
--25K
----
Current liabilities
-53.33%41.55K
-66.16%51.01K
-44.83%85.33K
-44.83%85.33K
-33.77%41.57K
-92.18%89.04K
-84.44%150.73K
-83.33%154.65K
-83.33%154.65K
-84.06%62.76K
Non current liabilities
Non current accrued expenses
----
----
----
----
----
----
----
----
----
4.12%148.95K
Total non current liabilities
-53.33%41.55K
-66.16%51.01K
-44.83%85.33K
-44.83%85.33K
-33.77%41.57K
-92.18%89.04K
-84.44%150.73K
-83.33%154.65K
-83.33%154.65K
-84.06%62.76K
Shareholders'equity
Share capital
3.66%20.06M
3.14%19.96M
3.14%19.96M
3.14%19.96M
0.00%19.35M
0.00%19.35M
0.00%19.35M
0.00%19.35M
0.00%19.35M
0.13%19.35M
-common stock
3.66%20.06M
3.14%19.96M
3.14%19.96M
3.14%19.96M
0.00%19.35M
0.00%19.35M
0.00%19.35M
0.00%19.35M
0.00%19.35M
0.13%19.35M
Gains losses not affecting retained earnings
2.74%1.71M
-9.91%1.66M
-42.09%1.66M
-42.09%1.66M
-52.46%1.66M
-53.70%1.66M
-45.89%1.85M
-11.42%2.87M
-11.42%2.87M
48.41%3.5M
Total equity
-41.60%335.38K
-56.51%291.9K
-47.86%401.08K
-47.86%401.08K
-93.56%430.87K
-92.24%574.32K
-91.93%671.21K
-92.29%769.22K
-92.29%769.22K
-35.70%6.69M
(Q2)May 31, 2024(Q1)Feb 29, 2024(FY)Nov 30, 2023(Q4)Nov 30, 2023(Q3)Aug 31, 2023(Q2)May 31, 2023(Q1)Feb 28, 2023(FY)Nov 30, 2022(Q4)Nov 30, 2022(Q3)Aug 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments -38.57%299.14K-49.09%249.92K-49.33%344.63K-49.33%344.63K53.72%381.81K4.14%486.93K-40.23%490.91K-66.81%680.17K-66.81%680.17K-92.66%248.39K
-Cash and cash equivalents -37.49%299.14K-49.09%249.92K-49.33%344.63K-49.33%344.63K53.72%381.81K2.35%478.56K-40.23%490.91K-66.81%680.17K-66.81%680.17K-92.66%248.39K
Total current assets -39.86%330.38K-55.60%286.9K-46.78%396.08K-46.78%396.08K-28.29%420.87K-50.46%549.32K-62.70%646.21K-76.80%744.22K-76.80%744.22K-85.16%586.9K
Non current assets
-Accumulated depreciation ---------------------------------------81.26K
Investment properties ------------------------------------18.26%529.64K
-Including:Financial assets designated as fair value through profit or loss, Total ------------------------------------18.26%529.64K
-Goodwill -------------------------------------7.39%5.42M
Regulatory assets -43.12%4.03K-92.23%6.45K-85.23%6.23K-85.23%6.23K-75.69%10.87K-76.30%7.08K255.94%83K49.10%42.19K49.10%42.19K5.86%44.72K
Liabilities
Current liabilities
-accounts payable -----66.16%51.01K-44.83%85.33K-44.83%85.33K-33.77%41.57K-89.38%89.04K-84.44%150.73K-83.33%154.65K-83.33%154.65K-84.06%62.76K
-Total tax payable --0--0--0--0--0--0--0--0--0--0
-Other payable -80.00%5K-80.00%5K-80.00%5K-80.00%5K--10K--25K--25K--25K--25K----
Current liabilities -53.33%41.55K-66.16%51.01K-44.83%85.33K-44.83%85.33K-33.77%41.57K-92.18%89.04K-84.44%150.73K-83.33%154.65K-83.33%154.65K-84.06%62.76K
Non current liabilities
Non current accrued expenses ------------------------------------4.12%148.95K
Total non current liabilities -53.33%41.55K-66.16%51.01K-44.83%85.33K-44.83%85.33K-33.77%41.57K-92.18%89.04K-84.44%150.73K-83.33%154.65K-83.33%154.65K-84.06%62.76K
Shareholders'equity
Share capital 3.66%20.06M3.14%19.96M3.14%19.96M3.14%19.96M0.00%19.35M0.00%19.35M0.00%19.35M0.00%19.35M0.00%19.35M0.13%19.35M
-common stock 3.66%20.06M3.14%19.96M3.14%19.96M3.14%19.96M0.00%19.35M0.00%19.35M0.00%19.35M0.00%19.35M0.00%19.35M0.13%19.35M
Gains losses not affecting retained earnings 2.74%1.71M-9.91%1.66M-42.09%1.66M-42.09%1.66M-52.46%1.66M-53.70%1.66M-45.89%1.85M-11.42%2.87M-11.42%2.87M48.41%3.5M
Total equity -41.60%335.38K-56.51%291.9K-47.86%401.08K-47.86%401.08K-93.56%430.87K-92.24%574.32K-91.93%671.21K-92.29%769.22K-92.29%769.22K-35.70%6.69M

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Latest Price
% Chg